Education
About Us
Working with TipRanks
Follow Us
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 43.27M | $ 46.02M | $ 41.40M | $ 36.94M | $ 34.44M |
| Gross Profit | $ 39.56M | $ 41.39M | $ 33.08M | $ 28.76M | $ 28.61M |
| Operating Income | $ -145.85M | $ -75.07M | $ -99.64M | $ -55.28M | $ -37.29M |
| EBITDA | $ -129.23M | $ -69.00M | $ -96.62M | $ -50.15M | $ -35.49M |
| Net Income | $ -130.87M | $ -70.80M | $ -102.25M | $ -58.42M | $ -45.39M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 370.91M | $ 331.05M | $ 144.56M | $ 211.56M | $ 44.91M |
| Total Assets | $ 418.46M | $ 355.18M | $ 180.36M | $ 263.37M | $ 91.72M |
| Total Debt | $ 21.86M | $ 4.91M | $ 46.35M | $ 39.20M | $ 40.99M |
| Net Debt | $ -77.85M | $ -276.36M | $ -49.28M | $ -139.39M | $ -3.92M |
| Total Liabilities | $ 81.96M | $ 88.86M | $ 83.99M | $ 78.99M | $ 73.18M |
| Stockholders' Equity | $ 336.50M | $ 266.32M | $ 96.37M | $ 184.38M | $ 18.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -130.28M | $ -1.61M | $ -67.16M | $ -50.25M | $ -14.80M |
| Operating Cash Flow | $ -126.23M | $ 1.88M | $ -65.00M | $ -50.10M | $ -14.44M |
| Investing Cash Flow | $ -219.35M | $ -3.31M | $ -17.27M | $ -33.12M | $ -362.00K |
| Financing Cash Flow | $ 164.02M | $ 187.07M | $ -690.00K | $ 216.90M | $ 37.49M |